93 related articles for article (PubMed ID: 325424)
1. Analysis of the results of treament of lung cancer patients with BCG according to the scheme of application of the bacillus.
Hadziev S; Kavaklieva-Dimitrova J
Neoplasma; 1977; 24():225-31. PubMed ID: 325424
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral Bacillus Calmette-Guérin immunotherapy prior to surgery for carcinoma of the lung: results of a prospective randomized trial.
Matthay RA; Mahler DA; Beck GJ; Loke J; Baue AE; Carter DC; Mitchell MS
Cancer Res; 1986 Nov; 46(11):5963-8. PubMed ID: 3530442
[TBL] [Abstract][Full Text] [Related]
3. Intralesional BCG application in malignant melanoma.
Sopková B; Kolár V
Neoplasma; 1976; 23(4):421-6. PubMed ID: 794745
[TBL] [Abstract][Full Text] [Related]
4. Survival of lung cancer patients treated with BCG and/or a soluble BCG fraction (F70) after surgery, radiotherapy and chemotherapy.
Hadźiev S; Kavaklieva-Dimitrova J; Mandulova P; Madźarova S; Spassova M
Neoplasma; 1980; 27(1):83-94. PubMed ID: 7374861
[TBL] [Abstract][Full Text] [Related]
5. [Bacillus Calmette Guerin as adjuvant treatment for superficial bladder tumors using two different therapeutic schemes].
Iturralde Codina A; Beyríe Tamayo W; Gozá León F; Muñoz YI
Arch Esp Urol; 2004; 57(6):606-18. PubMed ID: 15382436
[TBL] [Abstract][Full Text] [Related]
6. Experience with BCG adjuvant immunotherapy in stage II malignant melanoma.
Peter HH; Deutschmann EM; Schultheis W; Deicher H
Dev Biol Stand; 1977 Apr 13-15; 38():537-40. PubMed ID: 344106
[TBL] [Abstract][Full Text] [Related]
7. BCG immunotherapy in previously treated malignant melanoma patients.
Mujagić H; Kolarić K; Malenica B; Nola P
Biomedicine; 1979 Jun; 30(2):95-102. PubMed ID: 476270
[TBL] [Abstract][Full Text] [Related]
8. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J
Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510
[TBL] [Abstract][Full Text] [Related]
9. BCG immunotherapy of lung cancer in a district oncology dispensary. I. Study of 860 patients with histologic diagnosis.
Hadźiev S; Mandulova P; Kavaklieva-Dimitrova J; Penev K; Spassova M; Madźarova S
Neoplasma; 1982; 29(1):93-110. PubMed ID: 6280082
[TBL] [Abstract][Full Text] [Related]
10. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
Gutterman JU; Mavligit GM; Reed R; Burgess MA; Gottlieb J; Hersh EM
Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970
[TBL] [Abstract][Full Text] [Related]
11. Antibody responses to Bacillus Calmette-Guérin during immunotherapy in bladder cancer patients.
Winters WD; Lamm DL
Cancer Res; 1981 Jul; 41(7):2672-6. PubMed ID: 7018669
[TBL] [Abstract][Full Text] [Related]
12. [Immunotherapy of lung cancer using BCG cell-wall skeleton].
Yasumoto K
Kekkaku; 1977 Oct; 52(10):530-1. PubMed ID: 340747
[No Abstract] [Full Text] [Related]
13. Treatment of malignant melanoma by intratumoral injection of BCG.
Pinsky CM; Hirshaut Y; Oettgen HF
Natl Cancer Inst Monogr; 1973 Dec; 39():225-8. PubMed ID: 4595322
[No Abstract] [Full Text] [Related]
14. Recurrent malignant melanoma: effect of adjuvant immunotherapy on survival.
McCulloch PB; Dent PB; Blajchman M; Muirhead WM; Price RA
Can Med Assoc J; 1977 Jul; 117(1):33-6. PubMed ID: 861909
[TBL] [Abstract][Full Text] [Related]
15. Differences in biological activity among batches of lyophilized tice Bacillus Calmette-Guérin and their association with clinical course in Stage I lung cancer.
Bennett JA; Gruft H; McKneally MF; Zelterman D; Crispen RG
Cancer Res; 1983 Sep; 43(9):4183-90. PubMed ID: 6347367
[TBL] [Abstract][Full Text] [Related]
16. BCG immunotherapy of rat tumors of defined immunogenicity.
Baldwin RW; Pimm MV
Natl Cancer Inst Monogr; 1973 Dec; 39():11-9. PubMed ID: 4595312
[No Abstract] [Full Text] [Related]
17. Intrapleural BCG in postsurgical stage I non-small cell lung cancer.
Macchiarini P; Mussi A; Angeletti CA
Anticancer Res; 1989; 9(2):391-3. PubMed ID: 2546484
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy by BCG against prostate adenocarcinomas in anatomical compartments.
Pollard M; Luckert PH
Anticancer Res; 1994; 14(6B):2691-4. PubMed ID: 7872703
[TBL] [Abstract][Full Text] [Related]
19. [Immunologic capacity of cancer patients and BCG-CSW immunotherapy].
Yasumoto K; Manabe H; Yanagawa E; Nagano S; Ueda H
Nihon Kyobu Geka Gakkai Zasshi; 1979 Apr; 27(4):449-51. PubMed ID: 381535
[No Abstract] [Full Text] [Related]
20. Therapeutic effect of a water-salt extract from BCG in two patients with advanced breast cancer.
Hadziev S; Kavaklieva-Dimtrova J; Mandulova P
Neoplasma; 1975; 22(3):269-72. PubMed ID: 1099468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
